Synthesis and degradation of endothelin-1
- 1 June 2003
- journal article
- review article
- Published by Canadian Science Publishing in Canadian Journal of Physiology and Pharmacology
- Vol. 81 (6) , 503-510
- https://doi.org/10.1139/y03-032
Abstract
The endothelin-converting enzyme (ECE) is the main enzyme responsible for the genesis of the potent pressor peptide endothelin-1 (ET-1). It is suggested that the ECE is pivotal in the genesis of ET-1, considering that the knockout of both genes generates the same lethal developments during the embryonic stage. Several isoforms of the ECE have been disclosed, namely ECE-1, ECE-2, and ECE-3. Within each of the first two groups, several sub-isoforms derived through splicing of single genes have also been identified. In this review, the characteristics of each sub-isoform for ECE-1 and 2 will be discussed. It is important to mention that the ECE is, however, not the sole enzyme involved in the genesis of endothelins. Indeed, other moieties, such as chymase and matrix metalloproteinase II, have been suggested to be involved in the production of ET intermediates, such as ET-1 (1–31) and ET-1 (1–32), respectively. Other enzymes, such as the neutral endopeptidase 24–11, is curiously not only involved in the degradation and inactivation of ET-1, but is also responsible for the final production of the peptide via the hydrolysis of ET-1 (1–31). In this review, we will attempt to summarize, through the above-mentioned characteristics, the current wisdom on the role of these different enzymes in the genesis and termination of effect of the most potent pressor peptide reported to date.Key words: endothelin converting enzyme, endothelin-1, isoforms, human, inhibitors, chymase, ET-1 (1–31).Keywords
This publication has 78 references indexed in Scilit:
- No effect on central or peripheral blood pressure of systemic urotensin II infusion in humansBritish Journal of Clinical Pharmacology, 2002
- Processing of proendothelin‐1 by members of the subtilisin‐like pro‐protein convertase familyFEBS Letters, 2002
- Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agentsNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 2002
- Potent and Selective Non-Peptidic Inhibitors of Endothelin-Converting Enzyme-1 with Sustained Duration of ActionJournal of Medicinal Chemistry, 2000
- Endothelin converting enzyme is located on α-actin filaments in smooth muscle cellsCardiovascular Research, 1999
- The Expression of Endothelin-1 and Endothelin-Converting Enzyme-1 (ECE-1) are Independently Regulated in Bovine Aortic Endothelial CellsJournal of Cardiovascular Pharmacology, 1999
- Recombinant human endothelin-converting enzyme ECE-1b is located in an intracellular compartment when expressed in polarized Madin–Darby canine kidney cellsBiochemical Journal, 1998
- Novel Selective Quinazoline Inhibitors of Endothelin Converting Enzyme-1Biochemical and Biophysical Research Communications, 1998
- Expression of Endothelin‐Converting Enzyme in Both Neuroblastoma and Glial Cell Lines and Its Localization in Rat HippocampusJournal of Neurochemistry, 1997
- Pharmacological Profile of a Non-peptidic Dual Inhibitor of Neutral Endopeptidase 24.11 and Endothelin-Converting EnzymeBiochemical and Biophysical Research Communications, 1994